 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy BioMarin Pharmaceutical stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:BMRN! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about BioMarin Pharmaceutical stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
BioMarin Pharmaceutical Inc., a biotechnology company, develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Aldurazyme to treat mucopolysaccharidosis I, a genetic disease; Brineura for the treatment of late infantile neuronal ceroid lipofuscinosis type 2, a form of Batten disease; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company’s commercial products also comprise Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with mucopolysaccharidosis VI; Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme for adult patients with PKU; and Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis IV Type A, a lysosomal storage disorder. Its clinical and pre-clinical product pipeline includes valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; vosoritide, a peptide therapeutic that is in Phase III clinical trial for the treatment of achondroplasia, a form of disproportionate short stature in humans; and BMN 307, an AAV5 mediated gene therapy to normalize blood phenylalanine concentration levels in patients with phenylketonuria. The company serves specialty pharmacies; and end-users, such as hospitals and foreign government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has collaboration and license agreements with Sarepta Therapeutics and Asubio Pharma Co., Ltd.; and a preclinical collaboration and license agreement with DiNAQOR AG for the development of gene therapies to treat rare genetic cardiomyopathies. The company was founded in 1996 and is headquartered in San Rafael, California.
Volume médio
1.51 million shs
MERCADO CAP
$15.74 billion
Bolsa de Valores
NASDAQ
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NASDAQ:BMRN
|
Preparações farmacêuticas
|
Médico
|
8,466 shs
|
Below is a quick guide on how to buy NASDAQ:BMRN stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy BioMarin Pharmaceutical shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy BioMarin Pharmaceutical – Search for “”NASDAQ:BMRN”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought BioMarin Pharmaceutical stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
20 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for BioMarin Pharmaceutical in the last twelve months. There are currently 9 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” BioMarin Pharmaceutical stock.
Wall Street analysts have given BioMarin Pharmaceutical a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but BioMarin Pharmaceutical wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:BMRN stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy BioMarin Pharmaceutical stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy BioMarin Pharmaceutical stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NASDAQ:BMRN stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NASDAQ:BMRN stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:BMRN is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy BioMarin Pharmaceutical stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
BioMarin Pharmaceutical is scheduled to release its next quarterly earnings announcement on Thursday, February 25th 2021.
View our earnings forecast for BioMarin Pharmaceutical.
BioMarin Pharmaceutical will be holding an earnings conference call on Thursday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) issued its quarterly earnings data on Thursday, November, 5th. The biotechnology company reported $4.01 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $4.02. The biotechnology company earned $476.78 million during the quarter, compared to the consensus estimate of $454.64 million. BioMarin Pharmaceutical had a trailing twelve-month return on equity of 4.34% and a net margin of 45.74%. The company’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.30 earnings per share.
View BioMarin Pharmaceutical’s earnings history.
BioMarin Pharmaceutical’s stock was trading at $86.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BMRN stock has decreased by 1.4% and is now trading at $85.70.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:BMRN stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
20 equities research analysts have issued 1-year target prices for BioMarin Pharmaceutical’s shares. Their forecasts range from $77.00 to $218.00. On average, they expect BioMarin Pharmaceutical’s stock price to reach $116.50 in the next year. This suggests a possible upside of 35.9% from the stock’s current price.
View analysts’ price targets for BioMarin Pharmaceutical or view top-rated stocks among Wall Street analysts.
BioMarin Pharmaceutical’s management team includes the following people:
Mr. Jean-Jacques Bienaimé M.B.A., MBA, Chairman & CEO (Age 68, Pay $3.6M)
Mr. Jeffrey Robert Ajer, Exec. VP & Chief Commercial Officer (Age 59, Pay $1.17M)
Dr. Henry J. Fuchs, Pres of Worldwide R&D (Age 63, Pay $1.55M)
Mr. Brian R. Mueller, Exec. VP & CFO (Age 47)
Ms. Andrea L. Acosta, Group VP & Chief Accounting Officer (Age 42)
Dr. C. Greg Guyer Ph.D., CTO and Exec. VP of Global Manufacturing & Technical Operations
Mr. Lon Cardon Ph.D., Chief Scientific Strategy Officer
Traci McCarty, VP of Investor Relations
Mr. George Eric Davis, Exec. VP, Gen. Counsel & Sec. (Age 50)
Mr. Philip Lo Scalzo, Sr. VP & Chief Compliance Officer
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
161 employees have rated BioMarin Pharmaceutical CEO Jean-Jacques Bienaimé on Glassdoor.com. Jean-Jacques Bienaimé has an approval rating of 94% among BioMarin Pharmaceutical’s employees. This puts Jean-Jacques Bienaimé in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Some companies that are related to BioMarin Pharmaceutical include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Exact Sciences (EXAS), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), Novavax (NVAX), Repligen (RGEN), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and United Therapeutics (UTHR).
View all of BMRN’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other BioMarin Pharmaceutical investors own include Puma Biotechnology (PBYI), (MDVN) (MDVN), Incyte (INCY), First Solar (FSLR), United Airlines (UAL), Dynavax Technologies (DVAX), Micron Technology (MU), Vertex Pharmaceuticals (VRTX), (KITE) (KITE) and Freeport-McMoRan (FCX).
BioMarin Pharmaceutical trades on the NASDAQ under the ticker symbol “BMRN.”
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
BioMarin Pharmaceutical’s stock is owned by a variety of retail and institutional investors. Top institutional investors include Manning & Napier Group LLC (0.60%), California Public Employees Retirement System (0.52%), First Trust Advisors LP (0.46%), Victory Capital Management Inc. (0.41%), TCW Group Inc. (0.38%) and Swiss National Bank (0.38%). Company insiders that own BioMarin Pharmaceutical stock include Brian Mueller, Daniel K Spiegelman, David E I Pyott, George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Michael G Grey, V Bryan Lawlis and Willard H Dere.
View institutional ownership trends for BioMarin Pharmaceutical.
BMRN stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Daiwa Securities Group Inc., Sumitomo Mitsui Trust Holdings Inc., Frontier Capital Management Co. LLC, Rhenman & Partners Asset Management AB, First Trust Advisors LP, Scout Investments Inc., and Sowell Financial Services LLC. Company insiders that have sold BioMarin Pharmaceutical company stock in the last year include George Eric Davis, Henry J Fuchs, Jean Jacques Bienaime, Jeffrey Robert Ajer, Michael G Grey, V Bryan Lawlis, and Willard H Dere.
View insider buying and selling activity for BioMarin Pharmaceutical or view top insider-selling stocks.
BMRN stock was purchased by a variety of institutional investors in the last quarter, including State of Wisconsin Investment Board, DNB Asset Management AS, California Public Employees Retirement System, Must Asset Management Inc., Exchange Traded Concepts LLC, US Bancorp DE, NN Investment Partners Holdings N.V., and CMH Wealth Management LLC.
View insider buying and selling activity for BioMarin Pharmaceutical or or view top insider-buying stocks.
Shares of BMRN can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of BMRN stock can currently be purchased for approximately $85.70.
BioMarin Pharmaceutical has a market capitalization of $15.56 billion and generates $1.70 billion in revenue each year. The biotechnology company earns $-23,850,000.00 in net income (profit) each year or $0.07 on an earnings per share basis.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy BioMarin Pharmaceutical stock on the internet?
You can easily buy BioMarin Pharmaceutical stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading NASDAQ:BMRN stocks in a safe and complete environment to trade in.
Where to buy BioMarin Pharmaceutical stock?
You will first want to find a licensed broker that supports NASDAQ:BMRN stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:BMRN stocks in a safe and complete environment.
Is NASDAQ:BMRN stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:BMRN stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is BioMarin Pharmaceutical stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:BMRN is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in BioMarin Pharmaceutical stock.
How do you trade BioMarin Pharmaceutical stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for BioMarin Pharmaceutical stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:BMRN stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell BioMarin Pharmaceutical stock?
To sell your NASDAQ:BMRN stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best BioMarin Pharmaceutical stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:BMRN stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Bolsa de Valores de Paris (EPA)
Todas as ações da EPA Mais informações Ações da EPA O que é a Bolsa de Valores de Paris (EPA)? Agora
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
